Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
The original 1999 report was published as "Review of the potential health risks of radiofrequency fields from wireless telecommunications devices" / Expert Panel on the Potential Health Risks of Radiofrequency Fields from Wireless Telecommunications Devices - Ottawa, ON: Royal Society of Ca…
c.1 BC Cancer Agency VAN Library | Available |
The original 1999 report was published as "Review of the potential health risks of radiofrequency fields from wireless telecommunications devices" / Expert Panel on the Potential Health Risks of Radiofrequency Fields from Wireless Telecommunications Devices - Ottawa, ON: Royal Society of Ca…
c.1 BC Cancer Agency VAN Library | Available |
The original 1999 report was published as "Review of the potential health risks of radiofrequency fields from wireless telecommunications devices" / Expert Panel on the Potential Health Risks of Radiofrequency Fields from Wireless Telecommunications Devices - Ottawa, ON: Royal Society of Ca…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Cancer nursing : past, present, and future by Pamela J. Haylock; Symptom management issues in oncology nursing by Lisa Schulmeister and Barbara Holmes Gobel; The marriage of conventional cancer treatments and alternative cancer therapies by Georgia M. Decker; The changing legacy of cancer : issue…
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 February 2016
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available |
VC BC Cancer Agency VC Library Pamphlet File | Available |
VC BC Cancer Agency VC Library Pamphlet File | Available |
VC BC Cancer Agency VC Library Pamphlet File | Available |
VC BC Cancer Agency VC Library Pamphlet File | Available |
Announcing the Seventh National Community Cancer Control Summit in Prince George on June 12-13, 2009
VC BC Cancer Agency VC Library Pamphlet File | Available |
This report focuses on investment in research focused on cancer risk and prevention over a three-year period. Research is critiical to our understanding of cancer risk and effective cancer prevention strategies. The investment in cancer risk and prevention at $122.3M represented 11% of the overal…
c.1 BC Cancer Agency VAN Library | Available |
Session 1: Prevention of cancer and non-communicable diseases; Session 2: Managing population health to prevent and detect cancer and non-communicable diseases; Session 3: Coordinating care and treatment for cancer patients; Session 4: Knowledge exchange - translating research into practice and pol…
c.1 BC Cancer Agency VAN Library | Available |
Session 1: Improving and sustaining prevention in cancer control; Session 2: Mobilizing "all of society" for effective cancer control; Session 3: Improving population health : using data and evidence to support policy and programmes; Session 4: Improving integrated approaches to cancer treatment an…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |